Value-Based Pricing Could Boost Global Applicability Of NICE Appraisals

17 May 2012

• By John Davis

Value-based pricing will start in the U.K. in January 2014 for newly launched products, with prices taking into account innovation and societal benefit as well as NICE's usual clinical and cost-effectiveness analysis, U.K. Health Secretary Andrew Lansley tells NICE's annual conference.

Medicine appraisals conducted by the U.K. cost watchdog, the National Institute for Health and Clinical Excellence (NICE), will be of even greater use to other pricing and health care bodies around the world following the start of a value-based pricing (VBP) scheme for new medicines in the U.K. in January 2014.

This prediction, made by Health Secretary Andrew Lansley in a keynote speech to NICE's annual meeting in Birmingham on May...